Generalized Anxiety Disorder Assessment (GAD-7)

Abstract

The Generalized Anxiety Disorder Assessment (GAD-7) is a widely utilized, brief self-report measure designed to screen for and assess the severity of Generalized Anxiety Disorder (GAD) symptoms. Developed based on the diagnostic criteria outlined in the DSM-IV, this instrument consists of seven items that require respondents to evaluate the frequency of specific symptoms over the preceding two weeks. The GAD-7 is suitable for use in primary care settings and is appropriate for individuals aged 14 and older due to its simple language. It serves as an effective screening tool, with a recommended cutoff score of 10 or greater indicating the need for further clinical evaluation.

Keywords

Generalized Anxiety Disorder, GAD-7, anxiety screening, primary care, DSM-IV, mental health assessment, psychometrics, self-report scale.

Authors

Kurt Kroenke, Robert L. Spitzer, Janet B.W. Williams, Bernd Löwe, Oliver Decker, Stefan Müller, Elmar Brähler, Dirk Schellberg, Wolfgang Herzog, P. Yvonne Herzberg.

Purpose

The primary purpose of the GAD-7 is to provide a rapid, efficient screening instrument for detecting probable cases of Generalized Anxiety Disorder in clinical and non-clinical populations, particularly within primary care settings. It is specifically designed to align with the core symptomatic criteria for GAD.

Beyond initial screening, the scale is also utilized for monitoring treatment response and symptom severity over time. By quantifying the frequency of anxiety symptoms (ranging from 0 to 21), clinicians can track patient progress and determine the effectiveness of interventions.

Construct

The GAD-7 measures the psychological construct of generalized anxiety, characterized by excessive, uncontrollable worry and associated physical and cognitive symptoms. The scale operationalizes the core diagnostic features of GAD as defined by the American Psychiatric Association’s diagnostic manuals, focusing on the frequency of key symptoms such as feeling nervous, difficulty controlling worry, and trouble relaxing.

Although primarily focused on GAD, research has demonstrated that the GAD-7 possesses moderate utility in screening for other common anxiety disorders, including Panic Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder (PTSD), suggesting a broader measure of general anxiety distress.

Validity

The validity of the GAD-7 has been robustly established, particularly its criterion validity as a screening tool. Using a threshold score of 10, the GAD-7 demonstrates high performance for identifying GAD, achieving a sensitivity of 89% and a specificity of 82%.

Furthermore, its concurrent validity is supported by significant correlations with related psychological measures. Specifically, the GAD-7 showed a strong positive correlation with the PHQ-2 (r = 0.64, P < 0.001), a brief measure of depressive symptoms, reflecting the high comorbidity between anxiety and depression. Conversely, it demonstrated an expected moderate negative correlation with the Rosenberg Self-Esteem Scale (r = -0.43, P < 0.001), indicating that higher anxiety is associated with lower self-esteem.

Reliability

The GAD-7 exhibits excellent internal consistency, a key measure of reliability. Across various demographic subgroups examined by Löwe et al. (2008), the scale demonstrated an identical internal consistency coefficient (Cronbach’s alpha) of 0.89. This high alpha value confirms that the seven items consistently measure the same underlying construct of anxiety.

Factor Analysis

Psychometric investigations, including confirmatory factor analyses conducted by Löwe et al. (2008), strongly substantiated the 1-dimensional structure of the GAD-7. This finding confirms that the scale is essentially unidimensional, meaning all seven items contribute to measuring a single core factor—the severity of generalized anxiety.

Instrument

Test Type: Self-report screening and severity measure.

Format: Seven-item Likert-type scale, scored 0 (Not at all) to 3 (Nearly every day).

Language Available: Originally developed in English, validated norms established using a German sample (Löwe et al., 2008). Widely translated globally.

Population Group: General population, clinical samples, primary care patients.

Age Group: 14 years and older.

Population Details: Normative data were established using a large German community sample (N=5030, 53.6% female) with a mean age of 48.4 years (SD = 18.0). Interpretation of scores often requires consideration of gender, as women typically report slightly higher mean scores than men (3.2 vs. 2.7).

Test Methodology: Respondents rate the frequency of symptoms experienced over the past two weeks. Total scores range from 0 to 21. Scores are interpreted using established cutoffs (e.g., 5=mild, 10=moderate/clinical concern, 15=severe). Raw scores and gender-specific percentile ranks are often utilized for interpretation based on normative data.

Keywords

Screening instrument, Cronbach’s alpha, sensitivity, specificity, PHQ-2, self-esteem, psychometric validation, comorbidity.

Authors

Author ORCID Identifier: N/A (Information not provided in source content).

Affiliation Email addresses: N/A (Information not provided in source content).

Correspondence Address: N/A (Information not provided in source content).

Permissions & Fee and Test Year

The GAD-7 was developed by Kroenke, Spitzer, and Williams, with key validation work published in 2007 and 2008. The scale is frequently used in clinical practice and research, often available free of charge for non-commercial educational or research purposes, though specific permissions should be sought from the copyright holders (e.g., Pfizer or the developers) for commercial use. The initial validation focusing on screening performance was published in 2007 (Kroenke et al.) and the standardization and general population validation was published in 2008 (Löwe et al.).

Reference’s

Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-25.

Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical care, 46(3), 266.

Items of the Generalized Anxiety Disorder Assessment (GAD-7)

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

Instructions: Please read each statement and select from “Not at all” to “Nearly every day” to indicate how much the statement applied to you over the past two weeks.

The scoring metrics for each item are detailed below:

• Feeling nervous, anxious or on edge
• Not being able to stop or control worrying
• Worrying too much about different things
• Trouble relaxing
• Being so restless that it is hard to sit still
• Becoming easily annoyed or irritable
• Feeling afraid as if something awful might happen

Response Options and Scoring:

1. Not at all (0 points)
2. Several days (1 point)
3. More than half the days (2 points)
4. Nearly every day (3 points)

Total score ranges from 0 to 21.